Summary Damage arising from putative environmental sources has been found in the DNA of the gastric and colorectal mucosae of patients presenting with gastrointestinal disorders from the South Manchester area.
Gastrointestinal (GI) cancers are common, prognosis is poor and as yet with little sign of improvement. In this situation a fuller understanding of the aetiology of the disease could well lead to better control through improved strategies for prevention and earlier diagnosis.
Epidemiological studies suggest that GI cancers mainly result from exposure to environmental agents but the concensus remains inconclusive (Doll, 1988) . GI cancers, particularly those of the upper regions of the tract have been extensively linked to exogenous and endogenous exposures to N-nitrosocompounds and although this hypothesis is supported by good animal models, the evidence so far is not compelling (Magee, 1989) . Similarly, exposure to nitrates and nitrites as precursors of N-nitrosocompounds in the development of upper GI cancers finds some, but not conclusive epidemiological support (Preston-Martin & Correa, 1989) . Evidence for a causal association of nitrate in the development of gastric cancer has been questioned from an analysis of the literature (Forman, 1989) as well as by models which predict intragastric rates of nitrosation (Licht & Deen, 1988) .
If answers to these complex issues are to be found they will come eventually from direct measurements of exposure, rather than from estimates of potential exposure. Techniques are now available which permit the detection in target tissues of DNA damage caused by environmental agents. One such procedure is the use of radioimmunoassays (RIAs) to detect specific DNA lesions arising from exposure to alkylating agents. In the case of the simple alkylating agents, 13 products have been detected in DNA and of these, the promutagenic lesions 06-alkylguanine and 04-alkylthymine are thought to play a critical role in tumour initiation (Saffhill et al., 1985) . A monoclonal antibody (McAb) specific for the detection of 06-methyl-2'-deoxyguanosine (06-MedG) (Wild et al., 1983; Myers et al., 1988; Saffhill et al., 1988a) has been used extensively to measure relatively high concentrations of 06-MeG in small samples of DNA extracted either from cell cultures (Boyle et al., 1986 (Boyle et al., , 1987 or from mitochondrial DNA (Myers et al., 1988) . The same procedures can be used to measure very small amounts of this modified base in much larger samples of DNA thus permitting the detection of 06-MeG in human DNA. This has been achieved for oesophageal and stomach DNA of patients from Lin Xian, a district of N. China (Umbenhauer et al., 1985) and from SE Asia (Saffhill et al., 1988a) . In Lin Xian, oesophageal cancer risk is exceptionally high at 151 per 100,000 in males and 115 per 100,000 in females (Lu et al., 1986) . In Singapore (WHO, 1987) , the cancer risk in oesophagus and stomach is 14 and 37 per 100,000 in Chinese males (4 and 15, respectively in females). In these earlier studies there were few control samples. The aim of this study therefore was to investigate alkylation of DNA in a wide variety of both benign and malignant gastrointestinal conditions in a region where the incidence of GI cancers is similar or lower to that in Singapore, but much lower than that for Lin Xian. The world standardised rates for 1986 and 1987 in the NW cancer registry area for stomach, colon and rectum were approx. 18, 17 and 14 per 100,000 in males and 8, 15 and 8 per 100,000 in females, respectively (C. Hart, pers. communic) i.e. similar to the data published for these sites in the NW Registry for the period 1979 period -1982 period (WHO, 1987 . Samples were taken from surgical specimens of different GI organs from patients living in the Manchester area. A preliminary account (Saffhill et al., 1988a) (Kirby & Cook, 1957) and digested to nucleosides using DNAase I (0.1 mg ml 1), venom phosphodiesterase (0.03 U ml-') and alkaline phosphatase (0.3 U ml-') in 50 mM Tris-HCl, 5 mM MgCl2 and 3 mM sodium azide at pH 7.5 in the presence of 1 tLM 2'-deoxycoformycin for 4 h at 37°C. The latter was added to inhibit adenosine deaminase (Fox & Kelly, 1978) , which demethylates 06-MedG (O'Connor & Saffhill, 1979) and may occur as a contaminant of some DNA preparations. Hydrolysates of up to 5 mg DNA were applied to a column of Aminex-6 (25 cm x 1 cm) maintained at 50C during elution with 10 mM ammonium bicarbonate, pH 8.0. Where >5 mg DNA was available repeat separations were performed and the column fractions from both runs were pooled for analysis by RIA. This procedure separates the four major deoxynucleosides from 06-MedG, thereby enabling spectrophotometric measurement of the amount of normal purines in the DNA sample applied to the column and collection of the region of the elution profile which corresponds to 06-MedG. This system also separates ribonucleosides from deoxyribonucleosides and therefore permits analysis of 06-MedG in DNA which contains traces of RNA. The putative 06-MedG containing fractions and control fractions (i.e. a similar volume of buffer) from a blank region of the column elution profile were lyophilised after addition of 0.2-0.5 ml phosphate buffered saline containing 1% horse serum and 3 mM sodium azide. They were reconstituted in a similar volume of water for analysis by radioimmunoassay (RIA) using a monoclonal antibody to 06-MedG (Wild et al., 1983) . A full account of the above procedures and the RIA have been given previously (Wild et al., 1983 , Saffhill et al., 1988b , Myers et al., 1988 
Results
Gastrointestinal DNA obtained from people living in the South Manchester area contained low levels of 06-MeG in the range 0.01->0.30jmolesmole-' dA, but the pattern of alkylation was heterogeneous both within and between individuals (Tables I and II) .
Out of a total of 53 DNA samples analysed, 26 (49%) had no detectable 06-MeG (i.e. <-0.010 ;moles mole-' dA), although this ratio was biased by the high proportion (6/7) of malignant colorectal tumour DNA samples which were negative (see Table II . ) enm %00eI0-0r.I NC s 1 viduals were positive. In patients with malignant disease, tumour adjacent mucosal DNA was positive in 8/10 individuals, whereas tumour DNA was positive in only 1/7 individuals (Table II) . The mean O6-MeG level for the non-malignant mucosal samples was 0.041 ± 0.060 (5/11 positive individuals). Of the two ileal samples, one was negative and the other just positive (0.014pmolesmole-' dA). In patients with malignant disease the mean value for the tumour adjacent tissue was 0.083 ± 0.106 vs 0.003 ± 0.007 for the malignant tumour DNA itself (see Table III ). Alkylation was approximately 2-fold greater in the DNA of mucosa adjacent to malignant colorectal tumours than in the DNA of the mucosa of nonmalignant colorectal disease, 0.083 ± 0.106 vs 0.041 ± 0.060, respectively (Table III) .
Effects of life style and medication
No evidence of a relationship was observed for the effects of either smoking or alcohol consumption. Alcohol and tobacco consumption were not excessive in the patients studied (see Methods) and these factors did not appear to influence the levels of DNA alkylation.
Analysis was also performed for occupation and drug treatment but not surprisingly in this small sample no relationship was found.
Discussion
These data demonstrate that GI tissue DNAs obtained from a Manchester population contain O6-MeG which is most probably derived via an environmental source. While it is not yet possible to identify the exposures involved, it is evident that they can result in levels of DNA alkylation as high as those observed in Lin Xian where there is a very high cancer risk (Umbenhauer et al., 1985) .
As might be anticipated for environmental (low dose) exposures, the alkylation damage is heterogeneously distributed, both between and within individuals (Tables I and  II) . Immunohistochemical observations of DNA adduct formation for several different carcinogens have all indicated a heterogeneous distribution within a given tissue (e.g. NDMA, Fan et al., 1989; Aflatoxin B,, Wild et al., 1990 and Nnitrosobis (2-oxopropyl)amine, Bax et al., 1990) . In these cases metabolism is required for activation of the carcinogen to a chemically reactive form. The distribution of competent, activating enzyme systems in different cell types, therefore, is most probably responsible for this heterogeneity. After treatment, nuclear reactions can repair alkylation injury to DNA to a variable extent, thereby adding further to this heterogeneity (O'Connor et al., 1991) . In human tissue, similar factors would be expected to operate since in man and the rat, similar systems are responsible for the metabolism of environmental nitrosamines such as NDMA (Yoo et al., 1988) and for the repair of O6-MeG (Pegg, 1983; Gerson et al., 1986) .
Whilst the data reported here are consistent with the exposure to an environmental alkylating agent that requires metabolism for activation, there is no immediately obvious link with occupation, drug therapy or life style factors that might suggest such an exposure. It is worthy of note, however, that in rat liver, an organ which is competent for the metabolism of NDMA, tissue average DNA alkylation levels of 0.01-0.30 tmoles 06-MeG mole-' would arise from orally administered doses of 2-20 iLg NDMA Kg-' (Pegg & Perry, 1981) . Although exposure levels of -1 pg or more of NDMA per day have been reported for a variety of sources (e.g. see Scanlan, 1983) , no estimates of exposure arising from endogenous sources are available. Given that some cells may be DNA repair deficient (see above) these levels of DNA alkylation might accrue from repeated exposures to lower doses of environmental agents such as NDMA.
Comment on the overall levels of DNA alkylation observed must be made with reservation in view of the sample size. In the case of gastric DNA (Tables I and III) , the O6-MeG levels for non-malignant mucosa were lower than those for tumour DNA and similar to those for mucosa adjacent to malignant disease (0.024 ± 0.038; two of five samples vs 0.087 + 0.097; five of six samples and 0.017 ± 0.030; two of seven samples, respectively) if the atypically high values for Patient No. 1 are excluded. However, only the higher level of alkylation in the tumour DNA vs that of the adjacent mucosa approaches statistical significance (P = 0.07, Mann-Whitney universal test). In the colorectum (Tables II and III) , the levels of DNA alkylation were higher in the uninvolved mucosa adjacent to the malignant tumours than in the mucosa of patients with non-malignant disease and were lowest of all in the malignant tumours themselves (0.083 ± 0.106, 8/10 samples; 0.041 ± 0.060, 5/11 samples and 0.003 ± 0.007, 1/7 samples, respectively). In this case the higher level of DNA alkylation in the adjacent mucosa compared with that of the tumour DNA was significant (P<0.010, Mann-Whitney universal test).
A similar observation to the trend seen for the DNA in the colorectum has been made for the presence of 04-ethylthymine in the hepatic DNA of 33 patients with either cancer or non-malignant disease. In this study the mean values for hepatic 04-ethylthymine levels were significantly higher (4-5- fold) in patients with malignant disease (Huh et al., 1989) . This may be a particularly appropriate lesion to follow in liver since animal tissues have shown that although 04-ethylthymine occurs initially at levels which are many fold lower than 06-MeG, it is repaired slowly, if at all, and so tends to accumulate (Swenberg et al., 1984) . In the original study of alkylation damage in human DNA reported from Lin Xian, a district with high risk for oesophageal cancer in N. China (Umbenhauer et al., 1985) , the DNA from subjects with oesophageal and gastric cancer which had detectable levels of O6-MeG were, on average, 3 x and 1+ times higher respectively, than those of the controls. The controls were not truly representative, however, in that they came from a European source. In this latter study, as in the present report, there were many samples in which 06-MeG was not detected. 06-MeG has also been detected in one sample of stomach mucosa from 20 individuals in a group of Athens patients with either normal or atrophic gastric mucosa (Kyrtopoulos et al., 1990) , in placental DNA in 2/10 smokers and 3/10 non-smokers from the USA (Foiles et al., 1988) and in the DNA of 16/17 peripheral lung samples from smokers and non-smokers (Wilson et al., 1989 (Randerath et al., 1990; Cuzick et al., 1990) .
The fact that the DNA alkylation level was low or nondetectable in the malignant tumours of the colorectum is worthy of note and is in contrast to the relatively consistent and higher levels of alkylation in the DNA of gastric carcinoma. The low level in colorectal tumour DNA could be due to a variety of factors. These tumours were exposed to the GI lumen so that physical impedance to absorption of an exogeneous environmental agent seems unlikely, although there could be a change in membrane permeability. Loss of the capacity to metabolise carcinogens has been observed in animal tumours Cameron et al., 1976) and an increased capacity for DNA turnover or DNA repair could be responsible. There are, however, no strong precedents for the latter interpretation and on the contrary, reduced repair of 06-MeG has been observed in about 20% of established tumour cell lines (Yarosh, 1985) . In vivo, a wide range of DNA-alkyltransferase activities was found in human neural tumours (Wiestler et al., 1984) . Furthermore, in human colon, the effect of malignant change on this repair activity is as yet unclear; DNA-alkyltransferase activity may be increased, decreased, or remain unchanged when tumour tissue activity is compared with that of the adjacent mucosa (Margison et al., 1990) .
In conclusion, the levels of DNA alkylation reported in this study are similar to those observed in N. China (Umbenhauer et al., 1985) and in Singapore (Saffhill et al., 1988a) . The detection of promutagenic lesions in GI tissue DNA samples in several regions of the world now provides a possible explanation for the presence in some GI tumours of activated ras genes (Bos, 1989) which could arise as a result of miscoding events due to the presence of alkylated bases during DNA synthesis (Saffhill et al., 1985) . Although from these limited studies there is no direct indication of a relationship between cancer incidence and the extent of DNA alkylation it is anticipated that as data of this kind accumulate, it will not only be possible to define exposures to environmental sources of DNA damaging agents, but eventually to determine their importance and possibly also to begin to predict risk factors.
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